Literature DB >> 31928506

Effects of High-Intensity Interval Training Versus Moderate-Intensity Continuous Training on Epicardial Fat Thickness and Endothelial Function in Hypertensive Metabolic Syndrome.

Eun-Ah Jo1, Kyoung-Im Cho1,2, Jung-Jun Park3, Do-Sun Im4, Ji-Hyun Choi4, Bong-Jun Kim2.   

Abstract

Background: Hypertension is common in patients with metabolic syndrome (MS), and it is an important risk factor for cardiovascular-related morbidity and mortality. Compared to moderate-intensity continuous training (MICT), high-intensity interval training (HIIT) is considered a time-efficient exercise strategy for cardiometabolic health. We compared the effects of HIIT and MICT on epicardial fat thickness (EFT) and endothelial function in patients with hypertensive MS.
Methods: In total, 34 participants with hypertensive MS (mean age: 50.9 ± 7.9 years) were randomized to either the HIIT (n = 17) or MICT (n = 17) group. In the HIIT group, participants performed for 3 min at 40% heart-rate reserve (HRR), which was alternated with 3 min at 80% HRR, whereas participants in the MICT group performed at 60% of HRR thrice a week for 8 weeks. EFT was measured with echocardiography, and endothelial function was determined by quantifying endothelial progenitor cells (EPCs), nitric oxide (NO), and flow-mediated dilation (FMD).
Results: After exercise training, patients in both the groups showed significantly decreased EFT (P < 0.001 and P < 0.01) and improved FMD (P < 0.001 and P < 0.01). NO (P < 0.05) and EPCs (CD34/KDR, P < 0.01; CD34/CD117, P < 0.05; CD34/CD133, P < 0.05) were significantly improved in the HIIT group, but not in the MICT group. In addition, HIIT had a greater effect than MICT on FMD (group difference, P < 0.05) and EFT (group difference, P < 0.05). Conclusions: Compared to MICT, HIIT seems to better improve FMD and EFT. This finding suggests that HIIT could be more effective than MICT in improving endothelial function in patients with hypertensive MS.

Entities:  

Keywords:  endothelial function; epicardial fat; high-intensity interval training; hypertensive metabolic syndrome

Mesh:

Substances:

Year:  2020        PMID: 31928506     DOI: 10.1089/met.2018.0128

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  6 in total

Review 1.  The impact of different forms of exercise on circulating endothelial progenitor cells in cardiovascular and metabolic disease.

Authors:  Panagiotis Ferentinos; Costas Tsakirides; Michelle Swainson; Adam Davison; Marrissa Martyn-St James; Theocharis Ispoglou
Journal:  Eur J Appl Physiol       Date:  2022-01-12       Impact factor: 3.078

2.  [SARS-CoV-2 with transcription regulatory sequence motif mutation poses a greater threat].

Authors:  J Bei; G Xu; J Chang; X Wang; D Qiu; J Ruan; X Li; S Gao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-03-20

Review 3.  A Mixed Comparisons of Aerobic Training With Different Volumes and Intensities of Physical Exercise in Patients With Hypertension: A Systematic Review and Network Meta-Analysis.

Authors:  Zhenghui Lu; Yang Song; Hairong Chen; Shudong Li; Ee-Chon Teo; Yaodong Gu
Journal:  Front Cardiovasc Med       Date:  2022-01-21

4.  Relationship between Epicardial Fat Tissue Thickness and CRP and Neutrophil-Lymphocyte Ratio in Metabolic Syndrome Patients Over 65 Years.

Authors:  Gamze Ustuntas; Sema Ucak Basat; Ali Nazmi Calik; Ridvan Sivritepe; Okcan Basat
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-09-24

Review 5.  Epicardial Adipose Tissue: A Novel Potential Imaging Marker of Comorbidities Caused by Chronic Inflammation.

Authors:  Maria Grazia Tarsitano; Carla Pandozzi; Giuseppe Muscogiuri; Sandro Sironi; Arturo Pujia; Andrea Lenzi; Elisa Giannetta
Journal:  Nutrients       Date:  2022-07-17       Impact factor: 6.706

Review 6.  Exercise Training Effects on Circulating Endothelial and Progenitor Cells in Heart Failure.

Authors:  Christos Kourek; Alexandros Briasoulis; Virginia Zouganeli; Eleftherios Karatzanos; Serafim Nanas; Stavros Dimopoulos
Journal:  J Cardiovasc Dev Dis       Date:  2022-07-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.